Caplin Point Lab

{
  "main_header": {
    "sid": 640544,
    "name": "Caplin Point Lab",
    "stock_name": "Caplin Point Lab",
    "full_name": "Caplin Point Laboratories Ltd",
    "name_url": "stocks-analysis/caplin-point-lab",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,760.40",
    "chg": 29.8,
    "chgp": "1.72%",
    "dir": 1,
    "prev_price": "1,730.60",
    "mcapval": "13,271.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524742,
    "symbol": "CAPLIPOINT",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE475E01026",
    "curr_date": "Jan 28",
    "curr_time": "",
    "bse_nse_vol": "52.25 k",
    "exc_status": "Active",
    "traded_date": "Jan 28, 2026",
    "traded_date_str": "2026 01 28",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/caplin-point-lab-640544-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Caplin Point Laboratories Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-caplin-point-laboratories-ltd-fallingrising-3799188",
        "imagepath": "",
        "date": "2026-01-22 01:20:51",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>Caplin Point Laboratories has experienced a significant correction in recent trading sessions, with the stock losing 6.91% over the past week and 10.46% in the last month. This decline is markedly steeper than the Sensex’s corresponding losses of 1.77% and 3.56%, respectively. Year-to-date, the stock has fallen 6.26%, underperforming the Sensex’s 3.89% decline. Over the last twelve months, the stock’s performance has been particularly disappointing, registering a 21.31% loss while the Sensex gained 8.01%. Despite this short-term weakness, the stock has delivered strong long-term returns, with gains of 147.95% over three years and 255.33% over five years, significantly outpacing the Sensex’s 35.12% and 65.06% returns over the same pe..."
      },
      {
        "title": "Caplin Point Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-sell-3795860",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/CaplinPointLabo_mojoScore_3795860.png",
        "date": "2026-01-20 10:10:43",
        "description": "Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Caplin Point Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-sell-3786721",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/CaplinPointLabo_mojoScore_3786721.png",
        "date": "2026-01-09 10:10:44",
        "description": "Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Caplin Point Laboratories Faces Bearish Momentum Amid Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-faces-bearish-momentum-amid-technical-downgrade-3772585",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/CaplinPointLabo_technicaldot_3772585.png",
        "date": "2025-12-29 08:03:17",
        "description": "Caplin Point Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a shift in price momentum as technical indicators signal a bearish trend. Recent market data reveals a downward movement in the stock price alongside evolving technical parameters, suggesting a cautious outlook for investors."
      },
      {
        "title": "Caplin Point Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-sell-3772243",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/CaplinPointLabo_mojoScore_3772243.png",
        "date": "2025-12-28 10:10:03",
        "description": "Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 December 2025, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Caplin Point Laboratories Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-technical-momentum-shifts-amid-mixed-market-signals-3767757",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/CaplinPointLabo_technicaldot_3767757.png",
        "date": "2025-12-24 08:09:24",
        "description": "Caplin Point Laboratories has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of market forces within the Pharmaceuticals & Biotechnology sector. Recent evaluation adjustments reveal a transition from a bearish to a mildly bearish trend, underscoring a period of consolidation and cautious investor sentiment as the stock navigates key technical indicators."
      },
      {
        "title": "Caplin Point Lab Sees Revision in Market Evaluation Amidst Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-lab-downgraded-to-sell-by-marketsmojo-amid-valuation-and-technical-concerns-3761131",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/CaplinPointLab_mojoScore_3761131.png",
        "date": "2025-12-17 10:10:32",
        "description": "Caplin Point Lab, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting shifts in its financial and technical outlook. This adjustment comes amid contrasting signals from its valuation, profitability, and market performance over recent periods."
      },
      {
        "title": "Caplin Point Laboratories Faces Bearish Momentum Amid Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-faces-bearish-momentum-amid-technical-downgrade-3734613",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CaplinPointLabo_technicaldot_3734613.png",
        "date": "2025-11-28 08:03:57",
        "description": "Caplin Point Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a shift in price momentum as technical indicators signal a bearish trend. Recent evaluation adjustments highlight a cautious market stance amid subdued price action and mixed technical signals."
      },
      {
        "title": "Caplin Point Laboratories Forms Death Cross Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-forms-death-cross-signalling-bearish-trend-ahead-3734032",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CaplinPointLabo_dealthcross_3734032.png",
        "date": "2025-11-27 18:01:06",
        "description": "Caplin Point Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a potential weakening in the stock’s medium to long-term momentum."
      }
    ],
    "total": 577,
    "sid": "640544",
    "stock_news_url": "https://www.marketsmojo.com/news/caplin-point-laboratories-640544"
  },
  "announcements": [
    {
      "details": "Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated December 03, 2019, titled \"CAPLIN STERILES GETS USFDA APPROVAL FOR SODIUM NITROPRUSSIDE INJECTION\".",
      "source": "NSE",
      "caption": "Caplin Point Laboratories Limited - Press Release",
      "datetime": "03-Dec-2019"
    },
    {
      "details": "Caplin Point Laboratories Limited has informed the Exchange regarding 'Notice of Postal Ballot'.",
      "source": "NSE",
      "caption": "Caplin Point Laboratories Limited - Updates",
      "datetime": "22-Nov-2019"
    },
    {
      "details": "Caplin Point Laboratories Limited has informed the Exchange regarding Reappointment of Director of the company.",
      "source": "NSE",
      "caption": "Caplin Point Laboratories Limited - Reappointment",
      "datetime": "31-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "05 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Caplin Point Laboratories Ltd has declared <strong>150%</strong> dividend, ex-date: 12 Sep 25",
          "dt": "2025-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Caplin Point Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 19 Oct 16",
          "dt": "2016-10-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Caplin Point Laboratories Ltd falling/rising?

2026-01-22 01:20:51

Recent Price Movement and Market Comparison

Caplin Point Laboratories has experienced a significant correction in recent trading sessions, with the stock losing 6.91% over the past week and 10.46% in the last month. This decline is markedly steeper than the Sensex’s corresponding losses of 1.77% and 3.56%, respectively. Year-to-date, the stock has fallen 6.26%, underperforming the Sensex’s 3.89% decline. Over the last twelve months, the stock’s performance has been particularly disappointing, registering a 21.31% loss while the Sensex gained 8.01%. Despite this short-term weakness, the stock has delivered strong long-term returns, with gains of 147.95% over three years and 255.33% over five years, significantly outpacing the Sensex’s 35.12% and 65.06% returns over the same pe...

Read full news article

Caplin Point Laboratories Ltd is Rated Sell

2026-01-20 10:10:43

Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Caplin Point Laboratories Ltd is Rated Sell

2026-01-09 10:10:44

Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Caplin Point Laboratories Faces Bearish Momentum Amid Technical Shifts

2025-12-29 08:03:17

Caplin Point Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a shift in price momentum as technical indicators signal a bearish trend. Recent market data reveals a downward movement in the stock price alongside evolving technical parameters, suggesting a cautious outlook for investors.

Read full news article

Caplin Point Laboratories Ltd is Rated Sell

2025-12-28 10:10:03

Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 December 2025, providing investors with the latest insights into its performance and outlook.

Read full news article

Caplin Point Laboratories Technical Momentum Shifts Amid Mixed Market Signals

2025-12-24 08:09:24

Caplin Point Laboratories has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of market forces within the Pharmaceuticals & Biotechnology sector. Recent evaluation adjustments reveal a transition from a bearish to a mildly bearish trend, underscoring a period of consolidation and cautious investor sentiment as the stock navigates key technical indicators.

Read full news article

Caplin Point Lab Sees Revision in Market Evaluation Amidst Mixed Financial Signals

2025-12-17 10:10:32

Caplin Point Lab, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting shifts in its financial and technical outlook. This adjustment comes amid contrasting signals from its valuation, profitability, and market performance over recent periods.

Read full news article

Caplin Point Laboratories Faces Bearish Momentum Amid Technical Shifts

2025-11-28 08:03:57

Caplin Point Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a shift in price momentum as technical indicators signal a bearish trend. Recent evaluation adjustments highlight a cautious market stance amid subdued price action and mixed technical signals.

Read full news article

Caplin Point Laboratories Forms Death Cross Signalling Potential Bearish Trend

2025-11-27 18:01:06

Caplin Point Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a potential weakening in the stock’s medium to long-term momentum.

Read full news article

View All News